Related Articles
Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma
MELK as a potential target to control cell proliferation in triple‑negative breast cancer MDA‑MB‑231 cells
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway
Maternal embryonic leucine zipper kinase inhibits epithelial-mesenchymal transition by regulating transforming growth factor-β signaling
MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells